FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

H-PACE Program for the Improvement of Lifestyle Behaviors Among Children

Not Applicable

Active, not recruiting

Conditions: Pediatric Obesity

Interventions: Behavioral: H-PACE Behavioral Intervention
Other: Accelerometer
Other: Questionnaire Administration
Other: Supportive Care

First Posted Date: 2024-08-12

Last Posted Date: 2025-03-03

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 122

Registration Number: NCT06548074

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
New Mexico State University, Las Cruces, New Mexico, United States

Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm

Not Applicable

Not yet recruiting

Conditions: Pancreatic Neoplasm

Interventions: Other: Best Practice
Procedure: Palliative Care Consultation
Other: Survey Administration
Other: Tumor Board Review

First Posted Date: 2024-08-09

Last Posted Date: 2025-03-07

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 40

Registration Number: NCT06545344

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial

Phase 1

Recruiting

Conditions: Recurrent Myelodysplastic Syndrome
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Recurrent Acute Myeloid Leukemia

Interventions: Biological: Decoy-resistant interleukin-18
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration

First Posted Date: 2024-07-09

Last Posted Date: 2025-01-28

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 20

Registration Number: NCT06492707

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials

Not Applicable

Recruiting

Conditions: Digestive System Carcinoma
Breast Carcinoma
Genitourinary System Carcinoma

Interventions: Other: Best Practice
Behavioral: Patient Navigation

First Posted Date: 2024-07-03

Last Posted Date: 2024-12-31

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 100

Registration Number: NCT06484595

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico

Not Applicable

Not yet recruiting

Conditions: Cigarette Smoking-Related Carcinoma

Interventions: Behavioral: Smartphone App-delivered Smoking Cessation Intervention
Other: Health Promotion and Education
Other: Biospecimen Collection
Other: Questionnaire Administration

First Posted Date: 2024-04-26

Last Posted Date: 2025-04-08

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 120

Registration Number: NCT06386432

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial

Not Applicable

Conditions: Lung Carcinoma

Interventions: Other: Electronic Health Record Review
Other: Interview
Behavioral: Patient Navigation

First Posted Date: 2024-03-21

Last Posted Date: 2025-05-21

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 6772

Registration Number: NCT06324110

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1

Recruiting

Conditions: Castration-Resistant Prostate Carcinoma
Metastatic Prostate Adenocarcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions: Biological: Anti-STEAP1 CAR T-cells
Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Bone Scan
Procedure: Computed Tomography
Drug: Cyclophosphamide
Procedure: Echocardiography
Drug: Enzalutamide
Drug: Fludarabine
Procedure: Leukapheresis
Procedure: Magnetic Resonance Imaging
Procedure: Multigated Acquisition Scan
Procedure: Positron Emission Tomography

First Posted Date: 2024-02-01

Last Posted Date: 2025-03-30

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 48

Registration Number: NCT06236139

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Educational Intervention (Video)
Other: Survey Administration

First Posted Date: 2024-01-23

Last Posted Date: 2024-07-23

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 109

Registration Number: NCT06218615

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information

Not Applicable

Completed

Conditions: Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8

Interventions: Other: Educational Intervention
Other: Interview
Other: Survey Administration
Other: Telemedicine

First Posted Date: 2024-01-05

Last Posted Date: 2024-12-27

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 45

Registration Number: NCT06193070

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Phase 2

Recruiting

Conditions: Metastatic Prostate Adenocarcinoma
Stage IVB Prostate Cancer AJCC v8
Castration-Resistant Prostate Carcinoma

Interventions: Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Bone Scan
Procedure: Computed Tomography
Other: Fludeoxyglucose F-18
Other: Gallium Ga 68 Gozetotide
Drug: Lutetium Lu 177 Vipivotide Tetraxetan
Procedure: Positron Emission Tomography
Procedure: Single Photon Emission Computed Tomography
Drug: Vorinostat

First Posted Date: 2023-11-24

Last Posted Date: 2024-12-30

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 15

Registration Number: NCT06145633

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Home Terms & Conditions Privacy Policy